Showing results (1481-1490 of 1,692) with videos related to

Sort By:
Pageof 170
Analytical and Bioanalytical Chemistry|July 16, 2010
Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spotsRoland J W Meesters, Jeroen J A van Kampen, Mariska L Reedijk, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|September 26, 2020
Awakening after a sleeping pill: Restoring functional brain networks after severe brain injuryHisse Arnts, Willemijn S van Erp, Lennard I Boon, et al.
Infection and Immunity|October 18, 2017
Microbial Composition Predicts Genital Tract Inflammation and Persistent Bacterial Vaginosis in South African Adolescent FemalesKatie Lennard, Smritee Dabee, Shaun L Barnabas, et al.
The Oncologist|June 17, 2025
COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion reviewIgor Aurer, Paul Moss, Michel Goldman, et al.
Bone Marrow Transplantation|June 6, 2017
High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United KingdomS Kassam, E Chernucha, A O'Neill, et al.
Nature Communications|February 2, 2026
Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trialLennard Ostendorf, Jan Zernicke, Jens Klotsche, et al.
Journal of Neurochemistry|September 15, 2025
Extracellular Vesicles Released From Cortical Neurons Influence Spontaneous Activity of Recipient NeuronsFranco Luis Lombino, Mohsin Shafiq, Andreu Matamoros-Angles, et al.
American Journal of Physiology. Renal Physiology|September 13, 2018
The chemokine receptor CXErfan Ahadzadeh, Alva Rosendahl, Daniel Czesla, et al.
Plos One|May 13, 2020
Pooling individual participant data from randomized controlled trials: Exploring potential loss of informationLennard L van Wanrooij, Marieke P Hoevenaar-Blom, Nicola Coley, et al.
Blood|September 21, 2007
Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemiaEduardo Olavarria, Shamyla Siddique, Michael J Griffiths, et al.
Pageof 170